'Rebate walls' for drugs should be dismantled by the FTC - STAT

'Rebate walls' for drugs should be dismantled by the FTC - STAT

Opinion: Drug ‘rebate walls’ should be dismantled by the FTC’s antitrust arm

By DAVID BALTO

ADOBE

Rebate walls have inflated the price of drugs and stifled the ability of drug companies to compete on costs. The FTC should dismantle these walls.

READ MORE